# Aptbio

**Canonical:** https://apis.io/providers/aptbio/  
**Website:** https://equityzen.com/company/aptbio  
**APIs profiled:** 0

Aptbio is a biotechnology company focused on applying advanced protein engineering and AI-driven drug discovery platforms to develop novel therapeutics. The firm operates primarily in the Chinese market, with recent funding rounds reported by business news outlets. While a dedicated corporate website is not publicly reachable, the company is listed on equity research platforms and appears in industry databases such as Crunchbase and AptbioTech.

## Kin Score — 3.0 / 100 (minimal)

Scored 2026-10-17 under rubric 0.24.0. Trend: flat (+0.1 from 2.9).

| Facet | Score |
|---|---|
| Discoverability | 44.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 5.5 (matched via fallback).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Aptbio Domain Security** — TLSv1.3 · DMARC

## Tags

Biotechnology, Artificial Intelligence, Drug Discovery, China, Company

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/aptbio/). Scores are computed from the provider's own public artifacts under a published rubric.